Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 3
2(40.0%)
5Total
N/A(3)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02767778Not ApplicableTerminated

Low-frequency Pulsed Electromagnetic Fields (ELF-MF) as Treatment for Acute Ischemic Stroke

Role: collaborator

NCT02102984Not ApplicableCompleted

Covered Versus Uncovered Biliary Stents for Biliary Malignancies

Role: lead

NCT01524055Phase 3Completed

CO2 Insufflation During Single-Balloon-Enteroscopy

Role: collaborator

NCT01360346Phase 3Unknown

Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients

Role: collaborator

NCT01449084Not ApplicableCompleted

Early Pancreatic Duct Stent Removal in Preventing Post-endoscopic Pancreatitis

Role: lead

All 5 trials loaded